Perkins Coie Trust Company’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Perkins Coie Trust Company’s Portfolio EIGR Stock Details EIGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-6	Closed	-$39	–	300
2023 Q4	$39	Hold	6	–	–	﹤0.01%	295
2023 Q3	$53	Hold	6	–	–	﹤0.01%	606
2023 Q2	$124	Hold	6	–	–	﹤0.01%	228
2023 Q1	$158	Hold	6	–	–	﹤0.01%	236
2022 Q4	$208	Hold	6	–	–	﹤0.01%	226
2022 Q3	$1K	Hold	6	–	–	﹤0.01%	233
2022 Q2	$1K	Hold	6	–	–	﹤0.01%	231
2022 Q1	$1K	Hold	6	–	–	﹤0.01%	234
2021 Q4	$1K	Hold	6	–	–	﹤0.01%	226
2021 Q3	$1K	Hold	6	–	–	﹤0.01%	275
2021 Q2	$2K	Hold	6	–	–	﹤0.01%	277
2021 Q1	$2K	Hold	6	–	–	﹤0.01%	233
2020 Q4	$2K	Hold	6	–	–	﹤0.01%	242
2020 Q3	$1K	Hold	6	–	–	﹤0.01%	244
2020 Q2	$2K	Hold	6	–	–	﹤0.01%	250
2020 Q1	$1K	Hold	6	–	–	﹤0.01%	325
2019 Q4	$3K	Hold	6	–	–	﹤0.01%	274
2019 Q3	$2K	Hold	6	–	–	﹤0.01%	300
2019 Q2	$2K	Hold	6	–	–	﹤0.01%	302
2019 Q1	$2K	Hold	6	–	–	﹤0.01%	296
2018 Q4	$2K	Hold	6	–	–	﹤0.01%	290
2018 Q3	$2K	Hold	6	–	–	﹤0.01%	291
2018 Q2	$2K	Hold	6	–	–	﹤0.01%	294
2018 Q1	$2K	Hold	6	–	–	﹤0.01%	294
2017 Q4	$2K	Hold	6	–	–	﹤0.01%	287
2017 Q3	$2K	Hold	6	–	–	﹤0.01%	292
2017 Q2	$1K	Hold	6	–	–	﹤0.01%	299
2017 Q1	$2K	Buy	+6	New	+$2.07K	﹤0.01%	282

Other funds holding EIGR

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

AWP

Accretive Wealth Partners Parsippany, New Jersey $412M AUM 15.82% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Perkins Coie Trust Company's EIGR Position: Q1 2024 in Review

Perkins Coie Trust Company sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q1 2024, closing a stake of 6 shares — an estimated $39 sold.

Perkins Coie Trust Company first reported a position in EIGR in Q1 2017 and held it in 28 quarters. The position peaked at $3K in Q4 2019. 24 funds tracked by Wall St. Rank hold EIGR as of Q1 2024.

Perkins Coie Trust Company reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q1 2024 after selling out during the quarter.
Perkins Coie Trust Company sold 6 Eiger BioPharmaceuticals, Inc. shares in Q1 2024, an estimated $39.
Perkins Coie Trust Company first reported a position in Eiger BioPharmaceuticals, Inc. in Q1 2017 and held it in 28 quarters.
Perkins Coie Trust Company's Eiger BioPharmaceuticals, Inc. position peaked at $3K in Q4 2019.
24 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q1 2024.

Based on Perkins Coie Trust Company's 13F filing for Q1 2024, filed 12 Apr 2024.